Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neurologic Manifestations × Clomipramine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1 Obsessive-Compulsive Disorder 1 Neurologic Manifestations 1 Mental Disorders 1 Anxiety Disorders 1

Interventions

Temozolomide 2 Bevacizumab 2 Valproic Acid 1 Therapeutics 1 Sorafenib 1 Sildenafil Citrate 1 Radiotherapy 1 Irinotecan 1 Clomipramine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004310 2005-06-24

Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder

National Center for Research Resources (NCRR)

Phase 2 Unknown

Anxiety Disorders, Mental Disorders, Neurologic Manifestations, Obsessive-Compulsive Disorder, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡